Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

• Determine the efficacy of nebulized salbutamol/hypertonic saline combination in moderate to severe bronchiolitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Coordinación de Investigación en Salud, Mexico
• Treatments: Albuterol; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• All pediatric patients aged 2 months to 24 months of age, both genders attending the pediatric emergency service.

• With first episode of wheezing associated with respiratory distress and a history of upper respiratory tract infection.

• You have the evaluation of respiratory difficulty with Scale Hospital Sant Joan de Deu (HSJD) from 6 to 16 at entry points (moderate and severe degree).

Exclusion Criteria:

• Subjects with a history of previous wheezing, asthma, or who have received bronchodilator treatment before the present illness.

• Subjects with chronic lung disease, with heart disease, with congenital or acquired anatomic abnormalities of the airway.